NASDAQ: SILOSilo Pharma Inc Stock
$1.97+0.01 (+0.51%)
Updated Apr 18, 2024
SILO Price
$1.97
Fair Value Price
N/A
Market Cap
$5.60M
52 Week Low
$1.22
52 Week High
$3.05
P/E
-1.64x
P/B
0.91x
P/S
61.51x
PEG
N/A
Dividend Yield
N/A
Revenue
$72.10k
Earnings
-$3.70M
Gross Margin
91.9%
Operating Margin
-5,125.81%
Profit Margin
-5,132.6%
Debt to Equity
0.25
Operating Cash Flow
-$3M
Beta
0.15
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Score
–
Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SILO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SILO is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SILO is good value based on its book value relative to its share price (0.91x), compared to the US Biotechnology industry average (5.76x)
P/B vs Industry Valuation
SILO is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more SILO due diligence checks available for Premium users.
Be the first to know about important SILO news, forecast changes, insider trades & much more!
SILO News
Valuation
SILO price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-1.64x
Industry
15.68x
Market
41.33x
SILO price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.91x
Industry
5.76x
SILO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SILO's financial health
Profit margin
Revenue
$18.0k
Net Income
-$1.1M
Profit Margin
-6,219.8%
SILO's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
SILO's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$7.7M
Liabilities
$1.6M
Debt to equity
0.25
SILO's short-term assets ($7.68M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SILO's short-term assets ($7.68M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SILO's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
SILO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$910.0k
Investing
$4.4M
Financing
-$194.4k
SILO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
SILO vs Biotech Stocks
Silo Pharma Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.